Scott Randal W. Insider Trading Activity

Also formerly known as Scott Randal W
Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$1M
Insider Sells Quantity
6
Insider Sells Sum
$389,292.52

Insider Activity of Scott Randal W.

According to the SEC Form 4 filings, Scott Randal W., being in a position of

  1. director at BridgeBio Pharma, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 30000 shares for $2.09M,
    over all time since 2021-02-17, has bought 16000 shares for $1M, and sold 42000 shares for $2.48M.

Biography of Scott Randal W.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $2,092,4773100

Comparison of Insiders on Amount of Buys and Sells

2026-05-15SaleBridgeBio Pharma, Inc.
BBIO
director
10,000
0.0052%
$67.15$671,456+6.62%
2026-02-17SaleBridgeBio Pharma, Inc.
BBIO
director
10,000
0.0052%
$75.46$754,557-7.48%
2025-11-17SaleBridgeBio Pharma, Inc.
BBIO
director
10,000
0.0052%
$66.65$666,465+8.28%
2024-06-04SaleBridgeBio Pharma, Inc.
BBIO
director
1,500
0.0009%
$31.30$46,950+2.67%
2024-06-03SaleBridgeBio Pharma, Inc.
BBIO
director
1,000
0.0005%
$28.84$28,843-3.92%
2024-03-01SaleBridgeBio Pharma, Inc.
BBIO
director
2,500
0.0014%
$34.00$85,000-23.58%
2023-12-18SaleBridgeBio Pharma, Inc.
BBIO
director
2,000
0.0012%
$40.00$80,000-28.67%
2023-12-01SaleBridgeBio Pharma, Inc.
BBIO
director
2,500
0.0014%
$29.40$73,500-10.84%
2023-09-05SaleBridgeBio Pharma, Inc.
BBIO
director
2,500
0.0016%
$30.00$75,000-4.93%
2021-02-17PurchaseBridgeBio Pharma, Inc.
BBIO
director
16,000
0.0111%
$62.50$1M-21.37%
Total: 10
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.